Here, we quantified higher myoepithelial integrin β6 and periductal fibronectin expression in DCIS ducts associated with invasive disease in tissues, supporting the role for perturbed integrin signalling, ECM remodelling and an altered myoepithelial cell phenotype in driving DCIS progression. The gene discussed is FN1; the disease is ductal breast carcinoma in situ.